ImpediMed Lodges FDA Application to Clinically Assess Lymphedema in the Arm

ImpediMed Limited (ASIX: IPD) today announced the achievement of a major milestone, loding an application with the US Food and Drug Administration (PDA) to market the company’s new L-Dex U400 device.